Drug comparisons
Tirzepatide vs Insulin Degludec
Compare Tirzepatide (Mounjaro) vs Insulin Degludec (Tresiba) for T2 diabetes. Dual agonist vs basal insulin: efficacy, weight, risks, warnings.
No comparison dimensions are available for this page.
Clinical context
Type 2 diabetes patients requiring injectable therapy compare dual incretin agonist tirzepatide against long-acting insulin degludec for optimal control and weight management.
Bottom line
Tirzepatide typically outperforms basal insulin in weight and A1C for T2D but cannot replace insulin in all cases.
All medication comparisons